GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
N

NanoSphere Health Sciences NSHS.CN · CAD

Health Care · Canadian Securities Exchange · 🇨🇦 Canada

Compare

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

About NanoSphere Health Sciences

Its shares trade on Canadian Securities Exchange under the ticker NSHS.CN. It has been listed since 11 August 2005. In the fiscal year to 31 December 2019, it reported revenue of $218,000 and a net loss of $3.5m. At that date it held total assets of $333,700 and shareholders' equity of −$919,500.

NanoSphere Health Sciences, Inc. is a biotechnology company. The company is headquartered in Greenwood Village, Colorado. The company went IPO on 2005-08-11. The firm is focused on providing delivery of biologically active compounds through licensing and joint venture arrangements. The firm has created a patented NanoSphere Deliver System, a platform using nanotechnology in the biodelivery of supplements, nutraceuticals and over-the-counter medications for the cannabis, pharmaceutical and animal health industries. Its wholly owned subsidiary is NanoSphere Health Sciences, LLC (NanoSphere LLC). NanoSphere LLC is the Company’s operating division in the United States.

Figures and description from our data supplier, not checked against the company's own report.

Company facts

Sector
Health Care
Industry
Pharmaceuticals
Listed since
11 Aug 2005

Environmental, social and governance

Scores out of 100, from our data supplier

ESG
Overall
0
Environment
0
Social
0
Governance
0

SWOT analysis

AI-generated by our data supplier. Not written or checked by our editors.

AI-generated

Strengths

  • NanoSphere Deliver System enables biodelivery of supplements and nutraceuticals using nanotechnology.
  • Patented technology supports cannabis, pharmaceutical, and animal health industries.
  • Wholly owned subsidiary NanoSphere LLC operates as the U.S. business division.

Weaknesses

  • IPO listed on 11 August 2005, indicating limited market history.
  • Headquartered in Greenwood Village, Colorado, a small city with limited industry presence.
  • Focus on biodelivery of supplements and nutraceuticals may limit market diversification.

Opportunities

  • Expansion into cannabis industry through NanoSphere Deliver System platform.
  • Growth potential in pharmaceutical and animal health sectors using nanotechnology.
  • Licensing and joint venture arrangements can drive new revenue streams.

Threats

  • Regulatory challenges in cannabis industry may impact product development.
  • Competition in pharmaceutical sector could affect market share.
  • Nanotechnology delivery systems face evolving industry standards and regulations.

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.